Skip to main content Scroll Top

Actualités

  • Accueil
  • Alzheimer
  • Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Posts les plus vus
Clear Filters
[Initiatives] Ouverture de deux nouveaux centres à Paris pour un essai clinique sur la maladie d’Alzheimer
[Initiatives] Ouverture de deux nouveaux centres à Paris pour un essai clinique sur la maladie d’Alzheimer
15 mars 2026
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
6 juin 2018
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impact Gut Microbiota Dysbiosis
1 décembre 2019
1 décembre 2022

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
Read the article
CTAD 2023

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Partagez cet article